Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunome Q2 EPS $(0.60) Misses $(0.39) Estimate, Sales $2.36M Miss $2.55M Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:02pm
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.39) by 53.85 percent. This is a 30.43 percent decrease over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $2.36 million which missed the analyst consensus estimate of $2.55 million by 7.29 percent. This is a 44.55 percent decrease over sales of $4.26 million the same period last year.

Posted In: IMNM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist